2-05-2025, 15:59

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Notified -
Globe Newswire2-05-2025, 15:59
14-03-2023, 15:06

AMD Brings World-Class Performance of 4th Gen AMD EPYC™

New energy-efficient EPYC Embedded 9004 Series combines embedded system-optimized features, enhanced security and
Globe Newswire14-03-2023, 15:06
21-02-2023, 13:07

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical

KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire21-02-2023, 13:07
21-02-2023, 04:21

AMD to Present at Morgan Stanley’s Technology, Media and

SANTA CLARA, Calif., Feb. 20, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced that Mark Papermaster, chief
Globe Newswire21-02-2023, 04:21
13-02-2023, 19:03

ONL Therapeutics to Present at the XXVth Biennial Meeting

Oral presentation will review the scientific rationale for Fas receptor inhibition, a unique mechanism-of-action, in
Globe Newswire13-02-2023, 19:03
2-02-2023, 19:05

ONL Therapeutics to Present at 2023 BIO CEO & Investor

ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company
Globe Newswire2-02-2023, 19:05